PolyRemedy, a Boston, MA- and Mountain View, CA-based provider of personalized wound care systems, has closed a $20m Series C financing.
The round was led by Delphi Ventures, with participation from all existing investors MedVenture Associates, Advanced Technology Ventures and Flybridge Capital Partners.
This company intends to use the funds to commercialize its Personalized Woundcare System™ (PWS), which is designed to enable clinicians to document care through web-based assessment tools, order personalized wound dressings, and provide critical visibility into wound care data.
PolyRemedy plans to enhance the PWS mobile software assessment tools and advanced analytics, increase manufacturing capacity for its proprietary PolyFIT™ Antimicrobial Dressings, and build the sales and marketing team, which will be led by new Chief Commercial Officer Cameron McKennitt, who joins the company after five years at Kinetic Concepts.
PolyRemedy is led by President and CEO Mark Carbeau.